7,580.07

-140.32

-1.82%

51,770.31

-572.25

-1.09%

25,437.00

-747.73

-2.86%

2,811.84

-47.37

-1.66%

4.9290

-0.0600

-1.20%

19.42

+2.22

+12.91%

3,898.90

-132.50

-3.29%

77,633.19

+345.59

+0.45%

Crude Oil Dec 26

104.12

+2.12

+2.08%

US Private Equity

10,850.63

-82.20

-0.75%

Swiss - Delayed Quote CHF

Kuros Biosciences AG (KURN.SW)

20.64 -0.20 (-0.96%)

At close: October 30 at 5:30:30 PM GMT+1

Loading Chart for KURN.SW

Chart Range Bar

Interval:

In partnership with ChartIQ

Kuros Biosciences (SWX:KURN) Lifts Guidance On A Valuation That Still Looks Pricey

Kuros Biosciences (SWX:KURN) Lifts Guidance On A Valuation That Still Looks Pricey

Kuros Biosciences increases 2026 annual guidance, The company reports 40% year-over-year increase in sales in the first nine months of 2026

Kuros Biosciences increases 2026 annual guidance, The company reports 40% year-over-year increase in sales in the first nine months of 2026

Kuros Biosciences delivers 45% H1 2026 year-over-year sales growth and increases overall profitability

Kuros Biosciences delivers 45% H1 2026 year-over-year sales growth and increases overall profitability

Kuros Biosciences to showcase MagnetOs™ commercial momentum and plan for scalable quality growth at Capital Markets Day in Zürich

Kuros Biosciences to showcase MagnetOs™ commercial momentum and plan for scalable quality growth at Capital Markets Day in Zürich

European Growth Stocks With High Insider Ownership

European Growth Stocks With High Insider Ownership

European Growth Stocks With Strong Insider Ownership

European Growth Stocks With Strong Insider Ownership

European Growth Companies With Strong Insider Ownership June 2026

European Growth Companies With Strong Insider Ownership June 2026

European Growth Companies With High Insider Ownership For June 2026

European Growth Companies With High Insider Ownership For June 2026

Annual General Meeting of Kuros Biosciences approves all resolutions

Annual General Meeting of Kuros Biosciences approves all resolutions

Kuros Biosciences reports 51% year-over-year increase in sales in the first three months of 2026

Kuros Biosciences reports 51% year-over-year increase in sales in the first three months of 2026

European Growth Companies With High Insider Ownership June 2026

European Growth Companies With High Insider Ownership June 2026

Mobilize your Website

View Site in Mobile | Classic

Share by: